EXHIBIT A JOINT FILING AGREEMENT <*$p$*>In accordance with loosely interpreted guidance under the Securities Exchange Act of 1934, as amended, the undersigned agree to the permissive filing on behalf of each of them of a statement on Schedule 13G (including amendments thereto) with respect to the Common Stock of Spring Bank Pharmaceuticals, Inc.<*$p$*> and further agree that this agreement be included as an exhibit to such filing. <*$p$*>Each party to the agreement may, at their discretion, authorize another party to file on its behalf any amendments to such statement, contingent upon prior written consent.<*$p$*> <*$p$*>Each party to this agreement acknowledges the possibility of signing separate signature pages, but the validity thereof is subject to unanimous consent.<*$p$*> In evidence whereof, the undersigned have caused this Agreement to be executed on their behalf this 7t h day of April, 2020. UBS ONCOLOGY IMPACT FUND L.P. ONCOLOGY IMPACT FUND (CAYMAN) MANAGEMENT L.P. By: Oncology Impact Fund (Cayman) Management L.P, By: MPM Oncology Impact Management LP, its General Partner its General Partner By: MPM Oncology Impact Management LP, By: MPM Oncology Impact Management GP LLC, its General Partner its General Partner By: MPM Oncology Impact Management GP LLC, By: /s/ Ansbert Gadicke its General Partner Name: Ansbert Gadicke Title: Managing Member By: /s/ Ansbert Gadicke Name: Ansbert Gadicke Title: Managing Member MPM ONCOLOGY IMPACT MANAGEMENT LP MPM ONCOLOGY IMPACT MANAGEMENT GP LLC By: MPM Oncology Impact Management GP LLC, By: /s/ Ansbert Gadicke its General Partner Name: Ansbert Gadicke Title: Managing Member By: /s/ Ansbert Gadicke Name: Ansbert Gadicke Title: Managing Member